Advertisement
To help improve detection accuracy of lesions

NIH Releases Large-Scale Dataset of CT Images

0
Dataset may allow development of a universal lesion detector, which could be initial screening tool

July 2018 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for July 2018. This roundup includes...
Targeted steps can be taken to minimize future risks of lawsuits

Steps Can Be Taken by Doctors to Minimize Risk of Lawsuits

0
Steps include having a good handbook addressing legal issues, having risk committees within practices
Nurse navigators are playing an important role in oncology care at the Montefiore Medical Center in Bronx

Nurse Navigators Can Help to Improve Oncology Care

0
Nurse navigators include registered nurses and licensed practical nurses who work together in pairs
The National Guideline Clearinghouse and National Quality Measures Clearinghouse websites were taken down on July 16 when funding for these federal databases ended

National Guideline Clearinghouse Offline Due to Funding Cuts

0
An initiative of AHRQ, guideline.gov now offline due to lack of federal funding
Incorporating lay health workers into cancer care increases documentation of goals of care

Lay Health Workers Can Improve End-of-Life Cancer Care

0
Incorporating LHWs into cancer care increases goals-of-care documentation, patient satisfaction
There are very few published descriptions of programs that address the mistreatment of medical trainees

Few Published Programs Address Medical Trainee Mistreatment

0
Most common format of program is combination of lectures, workshops, and seminars
Introduction of genomic screening into routine health care is dependent on demonstration of clinical utility

Demonstrating Clinical Use Will Speed Genomic Screening

0
Field could advance more quickly if data from research participants, consumers got to clinic
Although physicians typically struggle with change

Learning to Change Important for Improving Practice

0
Physicians need to accept that the health care industry is changing and that change is difficult
Azedra (iobenguane) has been approved by the U.S. Food and Drug Administration to treat people 12 and older with rare adrenal gland tumors (pheochromocytoma or paraganglioma) that can't be surgically removed and have spread beyond the original site.

FDA Approves Azedra for Rare Adrenal Tumors

0
First systemic treatment for patients who experience tumor-related symptoms such as hypertension